Drugs / Entonox
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT01744184 | May 2013 → Feb 2022 | — | The Royal Bournemouth Hospital | Terminated | No outcome recorded Stop: Enrollment |
| Phase not applicable1 trial | ||||||
| — | NCT04321642 | Nov 2019 | — | Department of Medical Services Ministry of Public Health of Thailand | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 2/3 | NCT03167905 Comparator | Jun 2017 → Jul 2021 overdue | postpartum depression | KK Women's and Children's Hospital | Active not recruiting | Missed primary |
| Phase 4 | NCT01865721 Comparator | Jan 2013 → Apr 2014 | — | Sheffield Teaching Hospitals NHS Foundation Trust | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Entonox | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03167905 ↗ |
| Route | Inhaled | “Inhalations will be given for 3-5 minutes” NCT01744184 ↗ |